Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apollomics Inc. - Class A Ordinary Shares (NQ:APLM)

5.480 +0.320 (+6.20%)
Streaming Delayed Price Updated: 12:34 PM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,641
Open 5.305
Bid (Size) 5.450 (1)
Ask (Size) 5.560 (1)
Prev. Close 5.160
Today's Range 5.200 - 5.874
52wk Range 3.659 - 35.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga

Performance

YTD
-49.3%
-49.3%
1 Month
-3.4%
-3.4%
3 Month
-17.6%
-17.6%
6 Month
-27.4%
-27.4%
1 Year
-59.8%
-59.8%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
(APLM) - Analyzing Apollomics's Short Interest
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
From Apollomics Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
From Apollomics Inc.
Via GlobeNewswire
Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
From Apollomics Inc.
Via GlobeNewswire
Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
From Apollomics Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Dow Dips Over 300 Points; Walmart Raises FY25 Forecast
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Dow Falls 100 Points; Brady Posts Upbeat Results
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024
From Apollomics Inc.
Via GlobeNewswire
Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Apollomics Inc.
Via GlobeNewswire
Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress
From Apollomics Inc.
Via GlobeNewswire
S&P 500 Gains 1%; Home Depot Earnings Top Views
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is Apollomics Inc. - Class A Ordinary Shares publicly traded?
Yes, Apollomics Inc. - Class A Ordinary Shares is publicly traded.
What exchange does Apollomics Inc. - Class A Ordinary Shares trade on?
Apollomics Inc. - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Apollomics Inc. - Class A Ordinary Shares?
The ticker symbol for Apollomics Inc. - Class A Ordinary Shares is APLM on the Nasdaq Stock Market
What is the current price of Apollomics Inc. - Class A Ordinary Shares?
The current price of Apollomics Inc. - Class A Ordinary Shares is 5.480
When was Apollomics Inc. - Class A Ordinary Shares last traded?
The last trade of Apollomics Inc. - Class A Ordinary Shares was at 09/08/25 12:34 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.